A case of acrodermatitis continua of Hallopeau treated with etanercept

Jihun Park, Yoonsun Lee, Seongmin Noh, Suhyun Cho, Chang Ook Park, Kwang Hoon Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Acrodermatitis continua of Hallopeau (ACH) is a rare form of acropustular eruption characterized by a presence of aseptic pustules on inflammatory periungual or subungual regions. Frequently accompanied by paronychia, atrophic skin changes, onychodystrophy, and osteolysis of distal phalanges of the digits, it is considered to be a variant of pustular psoriasis with a chronic relapsing course and refractoriness to many therapeutic modalities. Here, we present a case of a 45-year-old female who presented with multiple pustules pathologically diagnosed as pustular psoriasis on her left thumb. She suffered from ACH for over a decade, and in the process experienced frequent relapses and showed poor response to numerous treatment modalities such as narrow band UVB, topical steroid, steroid intralesional injection, oral retinoids, 308 nm excimer laser, and oral immune suppressants. However, the patient showed dramatic clinical improvements to administration of etanercept (TNF-alpha antagonist, twice a week) for a period of one month. The cessation of etanercept led to recurrence of symptoms and marked deterioration of the skin lesion within a month again, but the re-initiation of treatment soon relieved the problem. After completion of a three months trial of etanercept, the cutaneous lesion subsided, and the patient is now successfully controlled with topical steroid maintenance therapy. Hereby, we report a patient with ACH successfully treated with etanercept.

Original languageEnglish
Pages (from-to)92-94
Number of pages3
JournalKorean Journal of Dermatology
Volume50
Issue number1
Publication statusPublished - 2012 Jan 1

Fingerprint

Acrodermatitis
Steroids
Psoriasis
Skin
Paronychia
Intralesional Injections
Recurrence
Excimer Lasers
Osteolysis
Thumb
Retinoids
Therapeutics
Tumor Necrosis Factor-alpha
Etanercept

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Park, Jihun ; Lee, Yoonsun ; Noh, Seongmin ; Cho, Suhyun ; Park, Chang Ook ; Lee, Kwang Hoon. / A case of acrodermatitis continua of Hallopeau treated with etanercept. In: Korean Journal of Dermatology. 2012 ; Vol. 50, No. 1. pp. 92-94.
@article{35246af005b8427c8575714faeea5d38,
title = "A case of acrodermatitis continua of Hallopeau treated with etanercept",
abstract = "Acrodermatitis continua of Hallopeau (ACH) is a rare form of acropustular eruption characterized by a presence of aseptic pustules on inflammatory periungual or subungual regions. Frequently accompanied by paronychia, atrophic skin changes, onychodystrophy, and osteolysis of distal phalanges of the digits, it is considered to be a variant of pustular psoriasis with a chronic relapsing course and refractoriness to many therapeutic modalities. Here, we present a case of a 45-year-old female who presented with multiple pustules pathologically diagnosed as pustular psoriasis on her left thumb. She suffered from ACH for over a decade, and in the process experienced frequent relapses and showed poor response to numerous treatment modalities such as narrow band UVB, topical steroid, steroid intralesional injection, oral retinoids, 308 nm excimer laser, and oral immune suppressants. However, the patient showed dramatic clinical improvements to administration of etanercept (TNF-alpha antagonist, twice a week) for a period of one month. The cessation of etanercept led to recurrence of symptoms and marked deterioration of the skin lesion within a month again, but the re-initiation of treatment soon relieved the problem. After completion of a three months trial of etanercept, the cutaneous lesion subsided, and the patient is now successfully controlled with topical steroid maintenance therapy. Hereby, we report a patient with ACH successfully treated with etanercept.",
author = "Jihun Park and Yoonsun Lee and Seongmin Noh and Suhyun Cho and Park, {Chang Ook} and Lee, {Kwang Hoon}",
year = "2012",
month = "1",
day = "1",
language = "English",
volume = "50",
pages = "92--94",
journal = "Korean Journal of Dermatology",
issn = "0494-4739",
publisher = "Korean Dermatological Association",
number = "1",

}

Park, J, Lee, Y, Noh, S, Cho, S, Park, CO & Lee, KH 2012, 'A case of acrodermatitis continua of Hallopeau treated with etanercept', Korean Journal of Dermatology, vol. 50, no. 1, pp. 92-94.

A case of acrodermatitis continua of Hallopeau treated with etanercept. / Park, Jihun; Lee, Yoonsun; Noh, Seongmin; Cho, Suhyun; Park, Chang Ook; Lee, Kwang Hoon.

In: Korean Journal of Dermatology, Vol. 50, No. 1, 01.01.2012, p. 92-94.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A case of acrodermatitis continua of Hallopeau treated with etanercept

AU - Park, Jihun

AU - Lee, Yoonsun

AU - Noh, Seongmin

AU - Cho, Suhyun

AU - Park, Chang Ook

AU - Lee, Kwang Hoon

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Acrodermatitis continua of Hallopeau (ACH) is a rare form of acropustular eruption characterized by a presence of aseptic pustules on inflammatory periungual or subungual regions. Frequently accompanied by paronychia, atrophic skin changes, onychodystrophy, and osteolysis of distal phalanges of the digits, it is considered to be a variant of pustular psoriasis with a chronic relapsing course and refractoriness to many therapeutic modalities. Here, we present a case of a 45-year-old female who presented with multiple pustules pathologically diagnosed as pustular psoriasis on her left thumb. She suffered from ACH for over a decade, and in the process experienced frequent relapses and showed poor response to numerous treatment modalities such as narrow band UVB, topical steroid, steroid intralesional injection, oral retinoids, 308 nm excimer laser, and oral immune suppressants. However, the patient showed dramatic clinical improvements to administration of etanercept (TNF-alpha antagonist, twice a week) for a period of one month. The cessation of etanercept led to recurrence of symptoms and marked deterioration of the skin lesion within a month again, but the re-initiation of treatment soon relieved the problem. After completion of a three months trial of etanercept, the cutaneous lesion subsided, and the patient is now successfully controlled with topical steroid maintenance therapy. Hereby, we report a patient with ACH successfully treated with etanercept.

AB - Acrodermatitis continua of Hallopeau (ACH) is a rare form of acropustular eruption characterized by a presence of aseptic pustules on inflammatory periungual or subungual regions. Frequently accompanied by paronychia, atrophic skin changes, onychodystrophy, and osteolysis of distal phalanges of the digits, it is considered to be a variant of pustular psoriasis with a chronic relapsing course and refractoriness to many therapeutic modalities. Here, we present a case of a 45-year-old female who presented with multiple pustules pathologically diagnosed as pustular psoriasis on her left thumb. She suffered from ACH for over a decade, and in the process experienced frequent relapses and showed poor response to numerous treatment modalities such as narrow band UVB, topical steroid, steroid intralesional injection, oral retinoids, 308 nm excimer laser, and oral immune suppressants. However, the patient showed dramatic clinical improvements to administration of etanercept (TNF-alpha antagonist, twice a week) for a period of one month. The cessation of etanercept led to recurrence of symptoms and marked deterioration of the skin lesion within a month again, but the re-initiation of treatment soon relieved the problem. After completion of a three months trial of etanercept, the cutaneous lesion subsided, and the patient is now successfully controlled with topical steroid maintenance therapy. Hereby, we report a patient with ACH successfully treated with etanercept.

UR - http://www.scopus.com/inward/record.url?scp=84863148637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863148637&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84863148637

VL - 50

SP - 92

EP - 94

JO - Korean Journal of Dermatology

JF - Korean Journal of Dermatology

SN - 0494-4739

IS - 1

ER -